ABCM

Abcam PLC

This asset is no longer available for investment.

View all assets

Price

return (12m)

0.00%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ABCM price

Abcam

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ABCM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ABCM

Valuation

P/E

0.00

Sector -3.98

Industry -3.98

P/BV

0.00

Sector 2.00

Industry 2.00

P/Revenue (PSR)

Sector -4.41

Industry -4.41

EV/EBITDA

Sector -245.01

Industry -245.01

EV/EBIT

Sector -666.51

Industry -666.51

P/EBITDA

Sector -4.07

Industry -4.07

P/EBIT

Sector -4.24

Industry -4.24

P/Total Assets

Sector 1.40

Industry 1.40

P/Net Current Assets

Sector -11.65

Industry -11.65

P/Working Capital

Sector -10.95

Industry -10.95

EPS

0.54

Sector -2.20

Industry -2.20

BVPS

3.97

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

75.58%

Sector 36.05%

Industry 36.05%

EBITDA Margin

26.72%

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

14.07%

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

11.05%

Sector -38.74%

Industry -38.74%

Net Profit Margins

16.69%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.20

Sector 0.03

Industry 0.03

Profitability

ROE

13.62%

Sector -66.41%

Industry -66.41%

ROA

9.54%

Sector -66.55%

Industry -66.55%

ROIC

4.44%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.35

Sector 2.90

Industry 2.90

Net Debt / EBITDA

0.00

Sector -14.63

Industry -14.63

Net Debt / EBIT

0.00

Sector -7.24

Industry -7.24

Net Debt / Equity

0.00

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

0.00

Sector -0.02

Industry -0.02

Equity/Assets

0.70

Sector 0.42

Industry 0.42

Liabilities/Assets

0.30

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

28.61%

Sector -

Industry -

5Y Earnings CAGR

-59.08%

Sector -

Industry -

FAIR VALUE OF Abcam ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$6.95

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ABCM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ABCM	0.00	0.00	13.62%	0.00%	$-	16.69%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ABCM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Abcam

Abcam PLC

Average Investor10 user rating

4.0 (2 people)

United States

28 years

Founded: 1998

2010

Time since IPO - 16 years

1.454

Employees

Abcam PLC (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $908.08 million.

The company employs approximately 1.454 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Abcam PLC reported $741.22 million in revenue, generating net income of $123.72 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ABCM.

Market cap

Net worth

$908.08 million

$908,080,000.00

Assets

$1.30 billion

$1,296,840,000.00

Total Shares Outstanding

229.00 million

229,000,000

Average Daily Trading Volume

$5.19 million

$5,185,678.84

Sector

Health Care

Industry

Biotechnology

ABCM

ABCM revenue and profits

Financial Results ABCM

DRAG THE FRAME TO SEE MORE DATA

ABCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$827.14 16,95% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$235.60 50,09% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$254.41 53,26% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$245.10 29,37% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$127.77 66,38% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$157.97 8,58% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$47.09 4,55% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$827.14 16,95% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$235.60 50,09% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$254.41 53,26% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$245.10 29,37% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$127.77 66,38% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$157.97 8,58% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$47.09 4,55% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Abcam (ABCM) today?

A cotação de Abcam (ABCM) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Abcam (ABCM) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Abcam (ABCM) e dados de ações do Ibovespa e mercados internacionais.

Quando Abcam (ABCM) paga dividendos?

Abcam (ABCM) não distribuiu dividendos no último ano.

Is Abcam (ABCM) a good investment?

Atualmente, Abcam (ABCM) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Abcam (ABCM) stock?

Investir em ações de Abcam (ABCM) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Abcam (ABCM) yield today?

A rentabilidade de Abcam (ABCM) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Abcam (ABCM) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ABCM

Abcam PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ABCM

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Abcam

Abcam PLC

United States

28 years

2010

1.454

PROFIT X PRICE ABCM

Financial Results ABCM

ABCM cash flow

Asset, Revenue and Profit Growth - ABCM

ABCM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions